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The accurate and rapid identification of bacteria isolated from the respiratory tract of patients with cystic 
fibrosis (CF) is critical in epidemiological studies, during intrahospital outbreaks, for patient treatment, and 
for determination of therapeutic options. While the most common organisms isolated from sputum samples are 
Pseudomonas aeruginosa, Staphylococcus aureus, and Haemophilus influenzae, in recent decades an increasing 
fraction of CF patients has been colonized by other nonfermenting (NF) gram-negative rods, such as Burk­
holderia cepacia complex (BCC) bacteria, Stenotrophomonas maltophilia, Ralstonia pickettii, Acinetobacter spp., 
and Achromobacter spp. In the present study, we developed a novel strategy for the rapid identification of NF 
rods based on Fourier transform infrared spectroscopy (FTIR) in combination with artificial neural networks 
(ANNs). A total of 15 reference strains and 169 clinical isolates of NF gram-negative bacteria recovered from 
sputum samples from 150 CF patients were used in this study. The clinical isolates were identified according 
to the guidelines for clinical microbiology practices for respiratory tract specimens from CF patients; and 
particularly, BCC bacteria were further identified by recA-based PCR followed by restriction fragment length 
polymorphism analysis with Haelll, and their identities were confirmed by recA species-specific PCR. In 
addition, some strains belonging to genera different from BCC were identified by 16S rRNA gene sequencing. 
A standardized experimental protocol was established, and an FTIR spectral database containing more than 
2,000 infrared spectra was created. The ANN identification system consisted of two hierarchical levels. The 
top-level network allowed the identification of P. aeruginosa, S. maltophilia, Achromobacter xylosoxidans, Acin­
etobacter spp., R. pickettii, and BCC bacteria with an identification success rate of 98.1%. The second-level 
network was developed to differentiate the four most clinically relevant species of BCC, B. cepacia, B. mul- 
tivorans, B. cenocepacia, and B. stabilis (genomovars I to IV, respectively), with a correct identification rate of 
93.8%. Our results demonstrate the high degree of reliability and strong potential of ANN-based FTIR 
spectrum analysis for the rapid identification of NF rods suitable for use in routine clinical microbiology 
laboratories.
The major causes of morbidity and mortality in patients with 
cystic fibrosis (CF) are chronic lung infections caused by 
Pseudomonas aeruginosa, Staphylococcus aureus, and Hae­
mophilus influenzae (20, 46). Nevertheless, in recent decades 
an increasing fraction of CF patients has been colonized by 
other emerging nonfermenting gram-negative bacilli, such as 
members of the Burkholderia cepacia complex (BCC), Stenotro­
phomonas maltophilia, Achromobacter xylosoxidans, Ralstonia 
pickettii, Pandoraea spp., andAcinetobacter spp. (9,10, 17, 47). 
Advances in the taxonomy of BCC revealed that it comprises at 
least nine distinct species (previously designated genomovars) 
which are very closely related (11, 34, 58). Furthermore, some
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Burkholderia species that do not belong to BCC, like B. gladioli, 
and species from other genera, such as Pandoraea and Ralsto­
nia, are commonly grouped with and referred to as B. cepacia- 
like organisms and share genotypic and phenotypic character­
istics with BCC bacteria (7, 8). Even though the frequency of 
infection with these emerging species is relatively low (20), 
they represent a significant challenge to clinical laboratories 
due to the misidentifications that often occur (11, 47). There­
fore, it has been reported that the microbiological detection of 
microorganisms in sputum samples from CF patients is one of 
the most labor-intensive, expensive, and sometimes unreliable 
procedure performed in microbiological laboratories (37). All 
nine species belonging to BCC are capable of colonizing CF 
patients, and some of them produce devastating consequences 
when they are the cause of lung infections in these patients (11, 
57). The accurate and rapid identification of the respiratory 
tract pathogens is required for the proper clinical management 
of these patients, for the study of intrahospital outbreaks, and
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to improve the understanding of the changing epidemiology of 
the microbiology in the lungs of CF patients (37, 46, 58). In 
most clinical laboratories, the identification of microorganisms 
isolated from sputum samples from CF patients is generally 
performed by using a combination of selective media and com­
mercially available phenotypic identification systems, such as 
the API 20NE system (bioMerieux, Marcy l’Etoile, France) or 
Vitek GNI Plus or Vitek 2 ID-GNB cards (bioMerieux) (3, 47). 
For final microbiological detection, several additional pheno­
typic tests are included for the differentiation among B. glad­
ioli, Pandoraea spp., R. pickettii, A. xylosoxidans, and some 
members of BCC (11, 26). However, misidentification may still 
occur at the species level, particularly among bacteria belong­
ing to BCC (11, 60). Consequently, isolates that are considered 
putative members of BCC should be further examined by ge­
notypic methods.
Various genotypic approaches are currently applied for the 
identification of bacteria isolated from sputum specimens and 
are used as alternatives or complements to phenotypic identi­
fication procedures. In this regard, 16S rRNA gene sequence 
analysis has been a widely accepted tool for molecular identi­
fication (17). Other techniques, such as rcc/l-based PCR (recA 
PCR) followed by restriction fragment length polymorphism 
(RFLP) analysis and sequence analysis, have also been used to 
identify BCC clinical isolates to the species level (33, 43, 56, 
57). Although these techniques are simple and initially useful, 
they have become confusing with the increasing species diver­
sity in BCC. Therefore, a new strategy involving multilocus 
sequence typing (MLST) has been applied and validated for 
the identification of BCC. This powerful technique allows both 
species and strain differentiation; and the sequence data are 
highly transferable, unambiguous, and useful for phylogenetic 
analysis (1). Although genotypic approaches to the identifica­
tion of clinically relevant microorganisms are finding their way 
into the field of clinical diagnostic microbiology, they are still 
expensive and laborious and are considered unattractive for 
routine application in busy clinical laboratories.
Modern Fourier transform infrared (IR) spectroscopy 
(FTIR) techniques constitute radically different approaches 
for the identification of microorganisms. The IR spectra of 
intact bacteria provide highly specific patterns that allow mi­
crobial cells to be distinguished at different taxonomic levels 
and have frequently been employed for the rapid and accurate 
identification of microorganisms even to the strain level (24, 
29, 35, 45). FTIR is easy to implement, allows the analysis of 
small quantities of biomass, and requires no consumables or 
reagents (38, 52). Standardization of the cultivation conditions 
and the sampling and measurement parameters enabled the 
creation of reference libraries containing spectra for well-iden­
tified microbes. These databases, which can be analyzed by 
using different algorithms, such as hierarchical cluster analysis 
(HCA) (2, 29), linear discriminant analysis (36), or analysis 
with artificial neural networks (ANNs) (45, 49, 55), make the 
identification of unknown microorganisms possible. In partic­
ular, the computer-based ANN pattern recognition method 
was reported to reliably solve problems with the identification 
of closely related microorganisms (45).
In this report we describe for the first time a new approach 
based on FTIR combined with ANNs for the discrimination 
and identification of nonfermentative gram-negative bacilli re­
covered from cultures of sputum from CF patients hospitalized 
in different CF centers and hospitals in Argentina between 
2004 and 2006. This approach constitutes a reliable, rapid, and 
specific means of identification of P. aeruginosa, R. pickettii, A. 
xylosoxidans, S. maltophilia, Acinetobacter spp., and the clini­
cally relevant species of BCC isolated from CF patients.
MATERIALS AND METHODS
Bacterial strains. A total of 15 references strain (kindly provided by Laura 
Galantemik, Laboratory for Microbiology, Gutierrez Hospital, Argentina) and 
169 clinical isolates of aerobic nonfermenting gram-negative rods recovered from 
sputum samples from 150 CF patients attending three different CF centers and 
hospitals in Argentina between 2004 and 2006 were used in this study (Table 1). 
The CF centers and hospitals are located in Buenos Aires Province (La Plata 
Children’s Hospital, Sor María Ludovica), Cordoba Province in central Argen­
tina (Santísima Trinidad Hospital, HST), and Buenos Aires City (Buenos Aires 
Clinical Hospital). Additional information on the origins of the strains and the 
identification methods applied to each strain is listed in Table 1.
Clinical isolates and reference strains were stored at — 70°C in brain heart 
infusion broth containing 10% glycerol. For FTIR analysis, they were unfrozen 
and subcultured once for 24 h on methylene blue (EMB) agar medium.
Isolation and phenotypic identification. The isolation of clinical isolates was 
performed according to clinical microbiolog}? practice recommendations for re­
spirator}? tract specimens from CF patients (11, 26, 27, 30, 50, 60). The isolates 
were first identified by using conventional biochemical methods (with the API 
20NE system or the Vitek 2 card [bioMerieux]). Subsequently, additional phe­
notypic tests which allow the discrimination of B. cepacia-Yks and BCC bacteria 
were applied to obtain the definitive phenotype (11, 26, 60). Antibiotic suscep­
tibilities were determined by the disk diffusion method on Mueller-Hinton me­
dium (Difco Laboratories), according to the methods outlined by the Clinical 
and Laboratory Standards Institute (formerly the National Committee for Clin­
ical Laboratory Standards; 1999) (40a). The identities of the strains identified as 
putative members of BCC by the aforementioned assays were further confirmed 
by molecular identification techniques.
Molecular identification of BCC isolates. The total chromosomal DNA of 
each isolate, which had previously been cultured in tryptic soy agar (TSA) at 37°C 
for 24 to 48 h, was extracted by the boiling-lysis method described by Seo and 
Tsuchiya (51). The identification of the clinical isolates and the confirmation of 
the identities of the reference strains were performed as described by Ma- 
henthiralingam et al. by PCR of the recA gene with primers BCR1 and BCR2 
followed by RFLP analysis with the Haelll restriction enzyme (33). A species­
specific PCR was used to the confirm species of the clinical isolates (33). The 
specific RFLP patterns obtained for the different BCC species were compared 
with those reported previously (16, 33, 51, 56, 58).
Identification by 16S rRNA gene sequence analysis. Total DNA was prepared 
as described by Sambrook et al. (48). Primers fD2 and rP2 (59), which are 
specific for the 16S rRNA gene, were used. Sequence analysis was performed as 
described by Bosshard et al. (3). The amplicons were purified and sequenced, 
and the fragments were analyzed with an automatic DNA sequencer (ABI Prism 
3100 genetic analyzer; Applied Biosystems). These sequences were analyzed with 
the BLASTN program of the Genetics Computer Group. A similarity score of 
s-99% with the reference sequence of a classified species was used to accept a 
species-level identification. If the score was between 98% and 95%, the clinical 
isolate was assigned to the corresponding genus.
FTIR, sample preparation, measurements, and data preprocessing. For FTIR 
measurements, both clinical isolates received from hospitals on EMB medium 
and bacteria obtained from stocks that had been subcultured for 24 h were 
subcultured on TSA medium (Oxoid, Basingstoke, United Kingdom) for 5 ± 
0.5 h at 37 ± 1°C. One loopful of these bacteria was directly harvested with a 
1-mm-diameter platinum loop and suspended in 120 pl distilled water. The 
suspensions were vortexed at a high speed (2,000 rpm) for 15 min on an MS2 
minishaker (IKA Works, Inc., Wilmington, NC) and centrifuged at 8,000 X g for 
5 min, the supernatant was discarded, and the pelleted cells were suspended in 
100 |jl1 of distilled water. An aliquot of 80 |jl1 was transferred to ZnSe optical 
plates and dried under moderate vacuum (0.1 bar) for 45 min to obtain trans­
parent bacterial films (24).
FTIR absorption spectra between 4,000 and 650 cm-1 were acquired on a 
Spectrum One FTIR spectrometer (Perkin-Elmer Instruments) with 6-cm_1 
spectral resolution and 64 scans. OPUS software (version 4.2; Bruker Optics 
GmbH, Ettlingen, Germany) was used for data preprocessing. The first deriva­
tives were calculated using the Savitzky-Golay algorithm with nine smoothing
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TABLE 1. Nonfermentative gram-negative bacterial strains used in this study
Species No. of isolates Origin/culture collection no.a Identification method6
P. aeruginosac 2 ATCC 9027, ATCC 27853
15 HNLP
BCCrf 1 HST 8684 RFLP with Haelll/species-specific recA PCR
1 HC BC05 RFLP with Haelll/species-specific recA PCR
B. cepacia 1 ATCC 25416 RFLP with Haelll
3 HST RFLP with Haelll/species-specific recA PCR
6 HC RFLP with Haelll/species-specific recA PCR
B. multivorans 2 LMG 13010, ATCC 17616 RFLP with Haelll
1 HST RFLP with Haelll/species-specific recA PCR
B. cenocepacia lineage IIIA 1 LMG 18863 RFLP with Haelll
yr HNLP RFLP with Haelll/species-specific recA PCR
ir HC RFLP with Haelll/species-specific recA PCR
31e HST RFLP with Haelll/species-specific recA PCR
B. cenocepacia lineage IIIB i LMG 16654 RFLP with Haelll
2 HC RFLP with Haelll/species-specific recA PCR
1 LMG 18870 RFLP with Haelll
B. stabilis 3 HC RFLP with Haelll/species-specific recA PCR
1 LMG 10929 RFLP with Haelll
B. vietnamiensis 1 LMG 21820 RFLP with Haelll
B. dolosa 1 LMG 19467 RFLP with Haelll
B. ambifaria 1 LMG 20983 RFLP with Haelll
B. anthina 1 LMG 14191 RFLP with Haelll
B. pyrrocinia 2 HC Sm 20/06, HC Sm 66/06 PCR for 16S rRNA
S. maltophilia 11 HC
13 HNLP
2 HC Ax 247/06, HC Ax 335/06 PCR for 16S rRNA
A. wlosoxidans 9 HC
10 HNLP
1 ATCC 19606
Acinetobacter baumannii 1 HC Ab 54/06 PCR for 16S rRNA
9 HNLP
Acinetobacter spp. 1 ATCC 27511
Ralstonia pickettii 1 HC Rp 127 PCR for 16S rRNA
a ATCC, American Type Culture Collection, Manassas, VA; DSMZ, Deutsche Sammlung von Mikroorganismen und Zellkulturen; LMG, Laboratorium Microbi- 
ologie Gent Culture Collection, Ghent, Belgium; HNLP, Hospital de Niños La Plata, La Plata, Argentina; HST, Hospital Santa Trinidad, Córdoba, Argentina; HC, 
Hospital de Clínicas, Buenos Aires, Argentina.
b All clinical isolates were identified by use of the API or the Vitek system and the nine additional phenotypic tests indicated in Materials and Methods (19). BCC 
clinical isolates were further identified by recA PCR-RFLP analysis with primers BCR'l and BCR2 and the Haelll restriction enzyme, followed by recA PCR with 
species-specific primers (50). Some clinical isolates belonging to genera other than BCC were randomly chosen to confirm their identities byl6S rRNA gene sequencing.
c Only nonmucoid P. aeruginosa strains were included.
d All BCC reference strains were kindly provided by Laura Galantemik, Hospital Gutierrez, Buenos Aires, Argentina.
e One strain was identified as B. cenocepacia lineage IIIA type D by recA PCR-RFLP analysis with Haelll, and the rest of the isolates were atypical strains identified 
as B. cenocepacia lineage IIIA but had a recA PCR-HaeIII RFLP profile not compatible with the ones previously described for B. cenocepacia (50).
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points to increase the number of discriminative features present in the spectra 
and to minimize problems with baseline shifts. To avoid interference from the 
biomass variations among the different samples, the first derivatives were vector 
normalized in the full range (25, 38). At least 10 spectra of each strain from four 
independent bacterial cultures were included in the analysis to account for 
possible sources of variance in the sampling procedure. The levels of reproduc­
ibility among the replicates for every strain were calculated as the averages plus
or minus 2 standard deviations of the so-called spectral distance (D), which is the 
measure of dissimilarity, where D is equal to (1 - r) X 1,000 and r is Pearson’s 
correlation coefficient (24, 38). OPUS software (version 4.0; Bruker Optics 
GmbH) was used to calculate the average D values and standard deviations for 
the different spectral ranges.
A database was built with the vector-normalized first-derivative spectra of the 
clinical isolates and reference strains given in Table 1. Before the spectra were
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introduced into the library, raw spectral data were subjected to a quality test 
(QT) with OPUS software (38). Spectral quality was ensured by taking into 
account the intensity, water vapor level, signal-to-noise values, and signal-to- 
water vapor values. Additionally, a so-called a factor, which was calculated from 
the ratio of the intensities at wavelengths of 1,738 cm-1 (/1,73s) and 1,540 cm-1 
(/i,54o) (Le., a ~ /i,73s//1,540) values of less than 0.25, was included in the 
QT. For spectral analysis, the database (which contained almost 2,000 vector- 
normalized first-derivative spectra) was divided into two subsets: (i) the training 
data set, which constituted the reference data of the first-derivative and vector- 
normalized spectra for the reference strains, the clinical isolates identified by 16S 
rRNA gene sequencing, and about 70% of the remaining clinical isolates ran­
domly chosen from among representatives of all species studied (altogether 131 
isolates), and (ii) the test data set, which contained the spectral data for the 
clinical isolates that were not included in the training data set (53 clinical 
isolates), which were used exclusively for external validation.
Semiquantitative determination of PHB. In order to adjust the culture condi­
tions so that poly-(3-hydroxybutiric acid (PHB) did not interfere with FTIR 
discrimination analysis, the PHB content was evaluated from the IR absorbance 
spectra, as reported previously (25). Briefly, the Z^s °f the ester carbonyl peak, 
used as a marker band to estimate the PHB content, and the /1;540 of the amide 
II peak, used as an internal standard of the total biomass, were calculated from 
the vector-normalized spectra. The semiquantitative estimation of PHB was 
calculated according to the equation a = /1,73s//1,540 with OPUS software (ver­
sion 4.0; Bruker Optics GmbH).
HCA. Analysis for discrimination between the different groups of bacteria 
studied was performed by HCA with the first-derivative spectra of the training 
data set. Dendrograms were obtained by using Ward’s clustering algorithm, and 
the D values, defined above, were calculated as a distance measure of similarity 
among the spectra (24, 29, 39).
ANN analysis. The whole database, which contained almost 2,000 first-deriv­
ative spectra for 169 clinical isolates and 15 reference strains, was used for the 
development of ANNs. NeuroDeveloper software (version 2.3; Synthon GmbH, 
Heidelberg, Germany) was used to develop and optimize a modular classification 
system. The first-derivative spectra included in the training data set were used for 
(i) preprocessing, (ii) training, and (iii) internal validation of the networks. In the 
data preprocessing step, the selection of the best wavelengths (feature selection) 
was performed in the predefined spectral windows of 2,800 to 3,100 cm-1 and 
1,650 to 900 cm-1 by using the COVAR algorithm (49). During the training 
procedure, the number of input neurons and the number of hidden neurons were 
optimized in the network topology in order to obtain good network performance. 
The internal validation was used to monitor the training process and to deter­
mine the optimal performance during the training process (49). To choose the 
spectra for use for internal validation, 10% of the spectra from each species in 
the training data set were randomly selected by the software. As an objective 
performance criterion of the ANNs, external validation was carried out with the 
test data set. This validation was used to establish the percentage of correct 
identifications as an objective measure to estimate the performance of the iden­
tification model.
TEM. The removal of pili and/or other fiber appendages that adhered to the 
bacteria was evaluated by transmission electron microscopy (TEM). Bacteria 
that had been grown on TSA medium for 5 h were suspended in distilled water 
and vortexed for different times (5 to 30 min) at different vortexing intensities 
(high, medium, slow) with an MS2 minishaker (IKA). A drop of both the original 
and the sheared suspensions was transferred to Formvar-coated grids. Five 
minutes later, the fluid was removed by absorbing it with filter paper and the 
grids were negatively stained with 2% phosphotungstic acid (pH 5.2) for 40 s. 
The grids were observed under a JEM 1200 EX JEOL transmission electron 
microscope (Servicio Central de Microscopia Electronica, Facultad de Ciencias 
Veterinarias, UNLP, Argentina) at 80 kV.
RESULTS AND DISCUSSION
Sample preparation for FTIR. At the beginning of our stud­
ies, we noticed that even though we were working on the basis 
of strictly standardized culture conditions, sample preparation 
procedures, and spectral data acquisition parameters, the bio­
logical variance achieved for replicate measurements for the 
different clinical isolates was too high to allow accurate dis­
crimination. In order to elucidate the reasons for this insuffi­
cient reproducibility, we focused our attention on those cellu-
lal
? $ 3«*1 rr,
Wavenumber (enr* )
FIG. 1. FTIR absorbance spectra in the region from 1,800 to 900 
cm for intact nonfermentative gram-negative rods grown on TSA 
medium at 37°C for 24 h. (a) PHB-producing bacteria. The bands 
indicated with arrows correspond to the main absorption bands as­
signed to PHB. (b) Non-PHB-producing bacteria.
lar components whose expression levels might be variable and 
might have relatively intense IR absorbance bands. It was pre­
viously reported that bacterial isolates recovered from CF pa­
tients could express PHB (28, 31). This intracellular compo­
nent shows a strong ester carbonyl band at 1,738 cm"1, 
accompanied by a number of additional bands at 1,383, 1,304, 
1,187, 1,135, 1,101, 1,059, and 976 cm 1 (38, 41). It was pre­
viously reported that these dominant IR absorption bands dis­
tributed throughout the whole mid-IR spectral range inter­
fered with the discrimination of other bacteria by FTIR (25). 
Therefore, we hypothesized that the presence of PHB might be 
one of the sources of interference when FTIR was used to 
discriminate among nonfermenting gram-negative bacilli. In 
experiments in which we screened for bands characteristic of 
PHB among the spectra of the reference strains and local 
isolates, we noticed that B. cenocepacia, B. cepacia, and R. 
pickettii could be considered PHB producers, while no PHB 
signals were found for the other species under our working 
conditions (growth on TSA medium at 37°C for 24 h). Figure 
la shows the FTIR absorbance spectra obtained for three 
clinical isolates of PHB-producing bacteria after 24 h of growth 
and the PHB absorption bands that interfered with the dis­
crimination of nonfermenting rods, while Fig. lb shows the 
spectra for five clinical isolates of non-PHB-producing bacteria
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FIG. 2. FTIR spectra (in the region from 1,800 to 600 cm ) ob­
tained during the growth of a B. cenocepacia clinical isolate as an 
example of the kinetics of PHB production of a nonfermentative rod 
growing on TSA medium at 37°C. The semiquantitative estimation of 
the PHB content, calculated from a (/1.738/f  1.540) values, is indicated at 
each time of growth. The a values were calculated as the ratio of the 
/i,738 of the ester carbonyl peak, used as a PHB marker band, and the
540 of the amide II peak, used as an internal standard of the total 
biomass (37).
(P. aeruginosa, A. xylosoxidans, Acinetobacter spp., B. mul- 
tivorans, and S. maltophilia).
In order to determine the environmental conditions under 
which PHB accumulation can be reduced to levels that would 
allow the reproducible discrimination of bacteria, different 
growth conditions and incubation times were tested. Figure 2 
shows the kinetics of PHB production for a clinical isolate of B. 
cenocepacia and the corresponding a values calculated from 
the FTIR spectra obtained for cells grown for different times 
on TSA medium at 37°C. For this clinical isolate, no significant 
PHB signals were detected during the first 5 h of incubation, 
with the corresponding a values being less than 0.17 ± 0.03. In 
the early exponential growth phase, the PHB signal started to 
increase, from an a value of 0.67 ± 0.04 at 6 h of incubation to 
the highest value of 1.87 ± 0.15 at 24 h of growth. Subse­
quently, the bacteria degraded PHB and its signal decreased 
again in the following hours, with an a value of 0.37 ± 0.09 
reached after 72 h of growth. We performed the same analysis 
with other B. cenocepacia strains and found that the kinetics 
and the relative amounts of PHB accumulated by the cells were 
not the same for all the strains tested. Some of the clinical 
isolates showed a maximum of PHB accumulation at 48 h of 
growth; other isolates started producing PHB after 10 h of 
incubation. In addition, the highest a values calculated for the 
different isolates varied from 0.52 ± 0.15 to 2.10 ± 0.17, irre­
spective of the genera or the species considered (B. cenocepacia. 
B. cepacia, and /?. pickettii). Nevertheless, for all the isolates 
tested (Table 1), no PHB production was observed before 
6 h of growth on TSA medium at 37°C. From these results we 
concluded that the cultivation time should be as short as pos­
sible and should be less than 6 h to avoid PHB interference 
with species discrimination by FTIR. On the other hand, a 
sufficient amount of biomass should be available after the 
selected incubation time to obtain spectra with an adequate 
signal-to-noise ratio to pass the QT described above. When 
these requirements are taken into account, an incubation time 
of 5 h was selected to achieve a sufficient cell mass, and we 
found that the a value should be less than 0.25 to ensure the 
absence of interfering PHB signals. It is important to note that 
the growth kinetics and, thus, the level of PHB production 
must depend on additional variables, aside from the culture 
medium, incubation time, temperature, and inoculum size, 
which cannot easily be controlled experimentally. Therefore, 
we defined that all spectra which failed the QT because of 
signal-to-noise ratios that were too low and/or because they 
had a values of >0.25 must be rejected and the measurements 
must be repeated.
Once PHB interference was eliminated, the level of repro­
ducibility for replicate measurements for different clinical iso­
lates was studied with bacteria grown under the previously 
selected conditions (growth on TSA medium at 37°C for 5 h). 
Figure 3a shows the vector-normalized first-derivative spectra 
in the 1,500- to 800-cm 1 range for two B. cenocepacia clinical 
isolates (isolates 57 and 69) from five independent cultivation 
experiments (three replicate measurements each) and the mi­
crographs of the corresponding cells obtained by TEM. As can 
be seen, significant heterogeneity among the replicate spectra 
for each strain was found in the 1,200- to 900-cin 1 region, 
which is mainly assigned to signals from carbohydrate vibra­
tions, and in the spectral region of 1,500 to 1300 cm known 
as the “mixed” region (24, 40). Cell components other than 
PHB that are also expressed at different levels and their chem­
ical compositions may exhibit IR absorption bands in these 
spectral regions and might therefore constitute a possible 
source of variance among replicates. These components are 
appendage fibers, such as pili and flagella. It has been reported 
that these fibers are expressed or coexpressed by most of the 
gram-negative bacteria present in the lungs of CF patients (P. 
aeruginosa, Burkholderia spp., S. maltophilia, and Acinetobacter 
spp.) (15,19, 21) and that a single pilus is a polymer formed by 
an ordered association of thousands of identical proteinaceous 
subunits (pilin), which might be glycosylated (4, 6, 42). There­
fore, we studied the spectral heterogeneity obtained after the 
removal of these pilus or flagella fibers from bacterial cells by 
vigorous shaking and subsequent centrifugation (21, 44). As­
says were performed with different times of vortexing (5 to 30 
min) and different vortexing intensities (low, medium, high) 
with a minishaker (MS2; IKA), and the spectral heterogeneity 
was evaluated. We observed that a significant reduction in the 
variance among replicates could be obtained after vortexing of 
the cells at a high intensity for 15 min, centrifugation, and 
separation of the cells from the pili. Figure 3b shows the 
first-derivative spectra of clinical isolates B. cenocepacia 57 and 
69 measured after application of the protocol described above 
and the corresponding micrographs obtained by TEM after 
vortexing of the cells.
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D values for the following spectral ranges (cm 1):
Species Isolate Before shearing After shearing and centrifugation
TABLE 2. Reproducibility levels obtained from cells before and after removing appendage structures calculated as D values 
for different spectral ranges"
3,000-2,800 1,500-1,300 1,200-900 3,000-2,800 1,500-1,300 1,200-900
B. cenocepacia 57 (HNLP) 2.13 = 1.62 6.19 ± 5.30 25.0 ± 23.2 0.75 ± 0.43 0.93 = 0.66 1.94 = 1.07
69 (HNLP) 2.71 ± 1.03 6.35 ± 5.29 30.1 ± 28.7 1.11 ± 1.07 1.82 ± 1.55 2.75 ± 0.66
15 (HST) 1.94 * 1.29 7.62 ± 6.64 13.2 ± 10.9 0.89 ± 068 0.95 * 1.06 1.70 ± 0.88
P. aeruginosa R2 (HST) 2.73 ± 1.96 8.36 ± 7.19 35.9 ± 40.2 1.20 ± 0.95 2.19 ± 1.07 3.43 ± 1.95
S. maltophilia 50428 (HST) 1.82 ± 1.69 10.12 ± 9.6 20.3 ± 23.2 0.31 ± 0.9 1.85 ± 1.34 2.99 ~ 1.98
35668 (HST) 1.9 ± 1.83 9.73 ± 8.25 15.3 ± 12.9 0.60 - 0.40 0.96 ± 0.57 2.8 ± 2.1
a D values were calculated (36) for the B. cenocepacia clinical isolates before and after shearing in the spectral regions 1,200 to 900 cm 1 (assigned to carbohydrates), 
1,500 to 1,300 cm ’ (mixed region), and 3,000 to 2,800 cm 1 (C—H stretching of > CH2 and —CH3). D values corresponding to one P. aeruginosa clinical isolate (isolate 
R2) and two S. maltophilia clinical isolates (isolates 50428 and 35668) are shown as examples of the typical D values obtained for genera other than Burkholderia. HNLP, 
Hospital de Niños La Plata, La Plata, Argentina: HST, Hospital Santa Trinidad, Cordoba, Argentina.
The variance among replicates in quantitative numbers was 
measured. We calculated the so-called D values for different 
IR spectral regions of the spectrum. By definition, the lowest D 
value indicates the highest reproducibility among replicates 
(24). Table 2 summarizes the spectral variances calculated for 
spectral windows of 3,000 to 2,800,1,500 to 1,300, and 1,200 to 
900 cm 1 before and after the application of shear stress to the 
cells. The D values calculated for clinical isolates B. cenocepa­
cia 57 and 69 before shearing were relatively high for both 
strains in the spectral region assigned to carbohydrates com­
pared to the values obtained, e.g., for the 3,000- to 2,800-cm 1 
window. Table 2 also indicates the maximum and minimum D 
values (30.1 ± 28.7 and 13.2 ± 10.9, respectively) obtained in 
the carbohydrate region among all the B. cenocepacia clinical 
isolates assayed and the typical D values obtained for the 
species P. aeruginosa and S. maltophilia. In all cases tested, the 
D values calculated after removal of the fiber appendages 
decreased by a factor of nearly 10 for the carbohydrate region 
and more than five times in the 1,500- to 1,300-cm 1 region, 
while the D values for the spectral range from 3,000 to 2,800 
cm 1 obtained after the removal of the detached fiber append­
ages from the cells by shearing and centrifugation decreased 
only by a factor of 2. The level of reproducibility obtained after 
shearing of the cells for 15 min at the maximum vortex inten­
sity turned out to be suitable for the discrimination of bacteria 
even down to the species level.
Therefore, to avoid interfering spectral signals due to vari­
ous amounts of PHB accumulation and to fiber appendage 
expression in the discrimination of all strains of nonfermenting 
rods isolated from sputum samples from CF patients by FTIR, 
the bacteria had to be incubated for 5 ± 0.5 h on TSA medium 
at 37 ± 1°C, suspended in distilled water, vortexed at a high 
speed for 15 min, and centrifuged. The spectra of the sus­
pended cells were then measured by FTIR, as described in the 
Materials and Methods section. This simple sampling protocol 
guaranteed a high level of reproducibility in a short time. It 
would be feasible to complete microbiological detection within 
a working day starting with the gram-negative nonfermentative 
rods obtained after 24 h of incubation on EMB agar, in view of 
the following requirements: 5 h of growth on TSA medium, 1 h 
for sample preparation, 15 min for the recording of spectral 
replicates, and a few minutes for data analysis.
Discrimination of gram-negative bacilli isolated from spu­
tum samples by HCA. HCA was applied in an attempt to 
develop a discrimination model able to differentiate six groups 
of nonfermentative bacteria isolated from CF patients (P. 
aeruginosa, R. pickettii,A. xylosoxidans, Acinetobacter spp., S. 
maltophilia, and BCC bacteria). The selection of the best com­
bination of spectral windows that produced the desired differ­
entiation was performed with the training data set. The spec­
tral windows 3,000 to 2,840, 1,200 to 900, and 1,400 to 1,250 
cm 1 were found to contribute maximally to the discrimination 
of the aforementioned groups of bacteria. By using the infor­
mation encoded in these spectral ranges as input data for the 
calculation of spectral distances and cluster analysis, a dendro­
gram was obtained (Ward’s algorithm and OPUS software 
[Broker Optics GmbH]), as shown in Fig. 4. This dendrogram 
shows a clear discrimination among the six different groups of 
bacteria analyzed. Although BCC bacteria were not discrimi­
nated to the species level, two main clusters (clusters a and b) 
were obtained. Interestingly, cluster a mainly contained the 
reference strains belonging to genomovars I to III, V to VII, 
and IX, while cluster b contained the clinical isolates and 
reference strains belonging to genomovars IV and VIII. These 
findings might be due to the fact that BCC bacteria, which are 
generally involved in chronic infection of the lungs of CF
FIG. 3. Vector-normalized first-derivative spectra of two B. cenocepacia clinical isolates (isolates 57 and 69) in the 1,500- to 800-cm 1 range, 
(a) The heterogeneity of 15 replicate measurements for each strain in the spectral ranges of 1,200 to 900 cm 1 and 1,500 to 1,300 cm 1 and the 
corresponding micrographs obtained by TEM are shown, (b) Vector-normalized first-derivative spectra measured after vortexing of similar cells 
at the maximum intensity for 15 min and subsequent centrifugation at 8,000 x g for 5 min to separate the cells from free pilus appendages in the 
supernatants. Micrographs of the cells obtained by TEM after they were vortexed without centrifugation show the small fragments of pili or fibers 
suspended in the supernatants.
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FIG. 4. FTIR-based dendrogram of results of HCA of gram-nega­
tive rods obtained by using the first-derivative spectra in spectral win­
dows of 3,000 to 2,840, 1,200 to 900, and 1,400 to 1,250 cm The 
calculation was done on the basis of the spectral distances and the 
Ward algorithm. BCC bacteria are grouped in two clusters: cluster a 
mainly contained reference strains belonging to genomovars I to III, V 
to VII, and IX, while cluster b contained the clinical isolates and the 
reference strains belonging to genomovars IV and VIII.
patients, where they live in biofilms, have a phenotypic evolu­
tion different from that of the reference strains (18, 22, 53). 
The performance of HCA for the discrimination of P. aerugi­
nosa, R. pickettii, A. xylosoxidans, Acinetobacter spp., S. malto- 
philia, and BCC was tested with the external validation data 
(test data set), with the results for 97.3% of the strains being in 
the correct cluster. One A. xylosoxidans clinical isolate, one S. 
nialtophilia clinical isolate, and three B. cenocepacia clinical 
isolates failed to cluster with the corresponding group and 
were thus misidentified. In the cases of A. xylosoxidans and .S'. 
maltophilia, this result could be due to the fact that the number 
of strains used was still not enough to cover the phenotypic 
variance within this group of bacteria. Similar results for opti­
mization of the classification system were previously shown by 
Rebuffo et al. (45).
The next step in the identification procedure was to test if 
another specific combination of spectral windows for cluster














FIG. 5. HCA showing the discrimination of the nine genomovars of 
BCC and two B. cenocepacia subtypes (subtypes IIIA and IIIB). The 
dendrogram was obtained by using the Ward algorithm, vector-nor­
malized first-derivative spectra, and the information contained in spec­
tral windows of 1,200 to 900, 1,450 to 1,350. 1,330 to 1,250, and 3.000 
to 2,800 cm HCA clearly discriminated among the nine species of 
BCC and two B. cenocepacia lineages (lineages IIIA and IIIB). Only 
reference strains were included in the analysis. Three replicate spectra 
from four independent experiments with each strain were used.
analysis different from the one used for differentiation to the 
genus level would be more appropriate for discrimination of 
the BCC bacteria to the species level. With this aim, the 11 
BCC reference strains listed in Table 1 were used in an HCA 
based on the spectral information contained in four different 
windows (1,200 to 900,1,450 to 1,350,1,330 to 1,250, and 3,000 
to 2,800 cm 1) to discriminate among the nine species of BCC 
and the two subtypes of B. cenocepacia. The dendrogram dis­
played in Fig. 5 exhibits the clear discrimination of the nine 
species of BCC and the two subtypes of B. cenocepacia, which 
belonged to lineages IIIA and IIIB. However, when this cluster 
analysis was challenged by use of the well-identified clinical 
isolates, clustering in two different distinct groups of clinical 
and reference strains was obtained. We tried the use of other 
spectral window combinations, but in all of our trials the main 
result was the discrimination of the clinical and the reference 
strains (data not shown). Thus, as was previously reported for 
closely related bacteria in other genera (45), HCA does not 
seem to consider optimally the appropriate spectral informa­
tion encoded in the spectra for the correct discrimination.
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FIG. 6. Schematic diagram of the classification system based on a modular ANN for the identification of nonfermentative gram-negative rods 
isolated from sputum samples from CF patients on the basis of FTIR spectra. On the first level of the ANN architecture, six groups of 
nonfermenting gram-negative rods (P. aeruginosa, S. maltophilia, A. xylosoxidans, BCC, R. pickettii, and Acinetobac ter spp.) are identified. In the 
second level of the classification scheme, the four most clinically relevant species of BCC bacteria (B. cepacia, B. multivorans, B. cenocepacia, and 
B. stabilis) are discriminated. These two independently developed modules were integrated into one ANN-based classification system.
Identification by ANN analysis. Taking into account the 
results described above, we applied ANN analysis, an advanced 
method based on so-called feature extraction techniques. With 
the aim of obtaining a clinically relevant identification system, 
this multivariate model was developed by considering the ep­
idemiology of BCC. From the known occurrence of different 
BCC species in CF patients, it is evident that all species of this 
complex are potentially capable of colonizing the lungs of CF 
patients (11, 57). Nevertheless, studies of the distribution of 
BCC species in CF patients in more than 10 different countries, 
including the United States, Canada, France, Italy, and the 
United Kingdom, revealed that most isolates recovered form 
CF patients belong to the species B. cenocepacia, B. mul­
tivorans, B. cepacia, and B. stabilis (5, 10, 12, 16, 23, 54). The 
distribution of members of BCC in CF patients also often 
shows a highly disproportionate representation of species (13, 
32). In this study, 84.3% of the isolates were B. cenocepacia, 
9.4% were B. cepacia, 3.1% were B. stabilis, and 1.1% were B. 
multivorans (by species-specific recA PCR identification; Table 
1). By taking into account the aforementioned BCC epidemi­
ological data, a model based on ANNs was developed. The 
model was able to accurately differentiate not only the six 
groups of nonfermenting gram-negative rods normally isolated 
from sputum samples from CF patients but also the four most 
clinically relevant species of BCC bacteria recovered from pa­
tients (genomovars I to IV). The use of a modular model, 
composed of two ANNs, allowed the optimization of each 
network with individual data preprocessing, feature selection, 
and network topology. These two independently developed 
modules were then integrated into one ANN-based classification 
system (49) (Fig. 6).
As described in the Material and Methods section, the da­
tabase used to develop this modular ANN system, which con­
tained almost 2,000 first-derivative spectra for 169 clinical iso­
lates and 15 reference strains, was divided into two subsets: (i) 
the training data set and (ii) the test data set, which contained 
the spectra for the clinical isolates that were not included in the 
training data set and that were exclusively used for external 
validation. The spectra for two isolates (isolates HST 8684 and 
HC BC05; Table 1) that were identified by molecular biology 
only to the genus level but that were identified as belonging to 
BCC were not used for training but were included in the test 
data set.
The optimal spectral features selected for use for the train­
ing of the top-level ANN was the most discriminative 60 wave­
lengths, two hidden units, and six output neurons. A fully 
connected feed-forward top-level ANN (Fig. 6) was trained by 
use of the Rprop algorithm (55). For the second-level ANN, 15 
wavelengths with the highest potential to discriminate between 
the BCC species were selected, and two hidden neurons were 
optimized for the four output neurons. An internal validation 
of the ANN-based FTIR identification model developed was 
performed. For this, individual spectra of each strain were 
randomly selected from the training data set (131 isolates, 
including reference strains; Table 3) and tested for the cor­
rectness of the identification. In this internal validation, a 
100% correct identification rate was obtained for all species 
tested (data not shown). When a spectrum belonging to a 
gram-negative nonfermentative rod isolated from a sputum 
sample was tested with this modular ANN model, a first step 
was used to check whether it was identified as a strain belong­
ing to the species P. aeruginosa, S. maltophilia, A. xylosoxidans, 
BCC, R. pickettii, or Acinetobacter spp. by using the top-level 
ANN, as shown schematically in Fig. 6. If the identification 
output at this level resulted in a member of BCC, the second- 
level ANN of the modular system was used to assign the spec­
tra to B. cepacia, B. multivorans, B. cenocepacia, or B. stabilis.
As an objective test of the performance of the model, an 
external validation was carried out with the first-derivative 
spectra for the 53 clinical isolates included in the test data set; 
the spectra for these isolates were not used for training or for 
internal validation. As indicated in Table 3, the top-level ANN
Downloaded from http://jcm
.asm
.org/ on August 23. 2019 by guest
2544 BOSCH ET AL. J. Clin. Microbiol..
TABLE 3. Identification results for modular ANNs obtained with 
the training data set and the test data set for external validation
Net level and 
microorganism
















P. aeruginosa 17 12 5 5(100)
BCC 107 78 29 29 TOO)
S. maltophilia 26 18 8 8(100)
A. xylosoxidans 21 15 6 5 (83.3) 1(16.7)
R. pickettii 2 2 2(100)
Acinetobacter spp. 11 8 3 3(100)
Total 184 131 53 52 (98.1) 1(1-9)
Second-level net1’
B. cepacia 10 7 3 3(100)
B. multivorans 3 2 1 1 TOO)
B. cenocepacia 83 58 25 23 (92) 2(8)
B. stabilis 4 3 1 1 TOO)
BCC 2 2 2(100)
Total 102 70 32 30 (93.8) 2 (6.2)
a There were no misidentifications.
b The training data set contained 131 isolates (including reference strains) and 
was used for training and internal validation. The internal validation, which was 
performed with the 131 isolates (including reference strains) from the training 
data set, yielded 100% correct identification for all the species.
c The test data set included 53 clinical isolates and was used for external 
validation.
d NeuroDeveloper software (version 2.3; Synthon KG) was used to develop 
and optimize a modular system. The whole database used contained almost 2,000 
first-derivative spectra obtained from 169 clinical isolates and 15 reference 
strains. The topology for the top-level net was 60 wavelengths, two hidden units, 
and six output neurons.
e The topology for the second-level net was 15 wavelengths and two hidden 
neurons optimized for the four output neurons.
BCC corresponded to two clinical isolates (isolates HST 8684 and HC BC05) 
that were identified as belonging to BCC by recA PCR with primers BCR'l and 
BCR2 but that could not be identified by PCR with species-specific primers.
did not identify only one A. xylosoxidans isolate. Interestingly, 
two strains (strains HST 8684 and HC BC05; Table 1) that 
could be identified only by molecular biology techniques as 
BCC strains were discriminated as belonging to BCC by the 
top-level network but could not be assigned to any of the BCC 
species by the second-level ANN (Table 3). The excellent over­
all performance of the modular ANN model was characterized 
by a 98.1% correct identification rate at the top level of the 
ANN and a 93.8% correct identification rate at the second 
level of the ANN. It should be emphasized that the ANN- 
based FTIR model developed here represents a system that 
can be used for the precise identification of P. aeruginosa, R. 
pickettii, A. xylosoxidans, Acinetobacter spp., S. maltophilia, and 
members of BCC. Additionally, it is able to discriminate BCC 
isolates to the species level and, in particular, can discriminate 
the four species that cause the majority of infections in CF 
patients (B. cepacia, B. multivorans, B. cenocepacia, and B. 
stabilis).
Chronic lung infections caused by the opportunistic patho­
gen that occur in CF patients are associated with extensive 
genetic adaptations and evolution of the infecting bacteria; 
they may evolve in response to selection pressure from the host 
environment and, probably, from other members present in 
the bacterial community (18, 22, 53). Therefore, our identifi­
cation system, like other phenotypic and genotypic identifica­
tion methodologies, requires continuous updating. However, 
the ANN-based FTIR technique has the advantage that it 
easily allows new isolates of the BCC species to be added to the 
database.
To extend phenotypic identification to most of the clinically 
relevant nonfermenting gram-negative bacilli isolated from CF 
patients, the present database will include further related spe­
cies in the future, particularly those belonging to the genera 
Achromobacter, Acinetobacter, and Ralstonia, although they oc­
cur at very low frequencies (9).
It is important to remark that our preliminary results suggest 
that the use of FTIR in combination with ANNs is able to 
discriminate different phenotypes among isolates that are pos­
itive byB. cenocepacia-specific PCR. This difference in discrim­
ination power would be assigned to the relatively low capacity 
of RLFP and BCC species-specific recA PCR to fully resolve 
the diversity within BCC compared with that of FTIR. We 
therefore consider that the use of the methodology based on 
FTIR developed in the present study, with the assistance of 
more powerful identification techniques, such as sequence­
based identification schemes like MLST (1, 14), would repre­
sent an important tool that could be used to solve ambiguous 
results when newly emerging species of BCC are detected in 
CF patients.
Conclusions. The accurate identification of pathogens from 
the respiratory tract of CF patients is crucial to ensure appro­
priate treatment and infection control. Among these organ­
isms, the taxonomy and identification of members of the genus 
Burkholderia have been always very complex. In the present 
study, we illustrate for the first time the enormous potential of 
FTIR combined with ANN methodologies for the rapid and 
accurate identification of six of the most clinically relevant 
gram-negative nonfermenting bacilli isolated from sputum 
samples from CF patients (P. aeruginosa, R. pickettii, A. xy­
losoxidans, Acinetobacter spp., S. maltophilia, and bacteria be­
longing to BCC) and the discrimination of the four BCC spe­
cies that occur at high frequencies in CF patients (B. cepacia, 
B. multivorans, B. cenocepacia, and B. stabilis).
We have put forward simple strategies that can be used to 
overcome experimental problems resulting from spectral in­
terference with PHB and the different types of pilus and/or 
flagellar appendages produced by gram-negative rods, par­
ticularly when they are isolated from sputum samples from 
CF patients. The proposed approach represents a significant 
advance in the identification of gram-negative nonferment­
ing bacilli for routine analysis.
As opposed to other methods, the method developed in 
the present study requires small quantities of cells and min­
imal sample preparation, is inexpensive, and can lead to 
identification results within a few hours. In the future, it will 
be further developed to enlarge the database with data for a 
wider range of microbial species, as well as larger numbers 
of strains and isolates of each species. The new identifica­
tion system proved to be reliable, rapid, and precise for 
practical use for the differentiation and identification of 
nonfermenting gram-negative bacteria isolated from sputum 
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Species No. of isolates Origin/culture collection no. Identification method
B. cenocepacia lineage IIIB 1 LMG 16654 RFLP with Haelll
2 HC RFLP with Haelll/species-specific 
recA PCR
B. stabilis 1 LMG 18870 RFLP with Haelll
3 HC RFLP with Haelll/species-specific 
recA PCR
B. vietnamiensis 1 LMG 10929 RFLP with Haelll
B. dolosa 1 LMG 21820 RFLP with Haelll
B. ambifaria 1 LMG 19467 RFLP with Haelll
B. anthina 1 LMG 20983 RFLP with Haelll
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HC Ax 247/06, HC Ax 335/06
HC
HNLP
PCR for 16S rRNA
A. baumannii 1 ATCC 19606
1 HC Ab 54/06 PCR for 16S rRNA
Acinetobacter spp. 9 HNLP
Ralstonia pickettii 1 ATCC 27511
1 HC Rp 127 PCR for 16S rRNA
4118
